| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.0043 | 1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.00073 | 1 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.00073 | 1 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.00069 | 1 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.00058 | 1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.00053 | 1 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.00044 | 1 |